Last week we presented Microviable Therapeutics at the online investors chapter of Keiretsu Forum and we got awarded as the best company, by the pool of investors present. Keiretsu Forum is a global investment community [...]
Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). On Tuesday 14th [...]
Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). Microviable Team joins [...]
Microviable Therapeutics SL, a preclinical stage biotechnology company developing orally administered biological drugs based on microbiota-derived products, announced 1.5 million euros seed funding from the private medical group Inmunomet Intolerancia y Disbiosis SL. Microviable [...]